Try our Advanced Search for more refined results

Wachtell-Led Swiss Pharma Co. Raises $340M In Offering

By McCord Pagan ( May 20, 2020, 3:08 PM EDT) -- Swiss biopharmaceutical company Idorsia Ltd., guided in the U.S. by Wachtell Lipton Rosen & Katz, said Wednesday it raised CHF330 million (about $340 million) in an upsized share offering whose proceeds will be used to help the company bring its inaugural insomnia treatment drug to market and to continue developing other products in its drug pipeline....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!